Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy
暂无分享,去创建一个
G. Remuzzi | N. Ohashi | Akihiko Kato | H. Yasuda | S. Baba | T. Iwakura
[1] Huhai Zhang,et al. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis , 2015, Scientific Reports.
[2] J. Klein,et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.
[3] E. Imai,et al. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy , 2014, Clinical and Experimental Nephrology.
[4] U. Panzer,et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.
[5] A. Segarra-Medrano,et al. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[6] N. Valtierra,et al. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.
[7] V. Tesar,et al. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] L. McWilliam,et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. , 2013, Kidney international.
[9] Y. Kim,et al. Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy , 2013, PloS one.
[10] B. Rovin,et al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression , 2013, Modern Pathology.
[11] U. Panzer,et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.
[12] J. Wetzels,et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.
[13] U. Panzer,et al. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[14] David M. Beck,et al. Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[15] D. Salant,et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.
[16] H. Debiec,et al. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.
[17] David M. Beck,et al. Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy , 2011 .
[18] David M. Beck,et al. Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[19] 克治 桑門. 海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .
[20] H. Debiec,et al. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy. , 2010, Journal of the American Society of Nephrology : JASN.
[21] David M. Beck,et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.
[22] D. Cattran. Management of membranous nephropathy: when and what for treatment. , 2005, Journal of the American Society of Nephrology : JASN.
[23] A. Komatsuda,et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] A. Komatsuda,et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.
[25] R. Monteiro,et al. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. , 1988, Clinical immunology and immunopathology.
[26] Y. Hamashima,et al. Distribution of IgG subclasses in membranous nephropathy. , 1984, Clinical and experimental immunology.